| Valerie Linda Katz, MD | |
|
234 E 149th St, Room 6-20, Bronx, NY 10451-5504 | |
| (718) 579-5900 | |
| (718) 579-4620 |
| Full Name | Valerie Linda Katz |
|---|---|
| Gender | Female |
| Speciality | General Surgery |
| Experience | 38 Years |
| Location | 234 E 149th St, Bronx, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144393729 | NPI | - | NPPES |
| 01376356 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 186454 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lincoln Medical & Mental Health Center | Bronx, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Downtown Bronx Medical Associates Pc | 9638082746 | 351 |
News Archive
A discovery at the Barbara Davis Center for Childhood Diabetes has identified a genetic risk for type 1 diabetes three to four times higher than previously thought possible.
Songbing Qin, MD, a visiting scientist to The Cancer Institute of New Jersey, has received the International - U.S. Annual Meeting Scientific Abstract Award at the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston this week.
A website where scientists can share data and computer models of cells, organs and whole organisms has been set up by a researcher from the University of Bath to help reduce the number of animals used in medical research.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
› Verified 7 days ago
| Entity Name | Downtown Bronx Medical Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689618407 PECOS PAC ID: 9638082746 Enrollment ID: O20031106000016 |
News Archive
A discovery at the Barbara Davis Center for Childhood Diabetes has identified a genetic risk for type 1 diabetes three to four times higher than previously thought possible.
Songbing Qin, MD, a visiting scientist to The Cancer Institute of New Jersey, has received the International - U.S. Annual Meeting Scientific Abstract Award at the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston this week.
A website where scientists can share data and computer models of cells, organs and whole organisms has been set up by a researcher from the University of Bath to help reduce the number of animals used in medical research.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Valerie Linda Katz, MD 215 Hillair Cir, White Plains, NY 10605-4516 Ph: (914) 761-1232 | Valerie Linda Katz, MD 234 E 149th St, Room 6-20, Bronx, NY 10451-5504 Ph: (718) 579-5900 |
News Archive
A discovery at the Barbara Davis Center for Childhood Diabetes has identified a genetic risk for type 1 diabetes three to four times higher than previously thought possible.
Songbing Qin, MD, a visiting scientist to The Cancer Institute of New Jersey, has received the International - U.S. Annual Meeting Scientific Abstract Award at the 54th Annual Meeting of the American Society for Radiation Oncology (ASTRO) being held in Boston this week.
A website where scientists can share data and computer models of cells, organs and whole organisms has been set up by a researcher from the University of Bath to help reduce the number of animals used in medical research.
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company dedicated to developing and commercializing first-in-class oncology therapeutics, today announced that it has been issued a United States patent (No. 8,314,100), titled "1-[6,7-substituted alkoxyquinoxalinyl) aminocarbonyl]-4-(hetero) arylpiperazine derivatives."
› Verified 7 days ago
Dr. Sydney George Mccalla, M.B.B.S Surgery Medicare: Accepting Medicare Assignments Practice Location: 234 E 149th St, Bronx, NY 10451 Phone: 718-579-5000 Fax: 718-579-4620 | |
Cosman Camilo Mandujano Bejarano, Surgery Medicare: Medicare Enrolled Practice Location: 111 E 210th St, Bronx, NY 10467 Phone: 832-675-0676 | |
Dr. Mahalingam Sivakumar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1650 Selwyn Ave, Acn Morris, Bronx, NY 10457 Phone: 718-960-1320 Fax: 718-960-1051 | |
Dr. Rajendra J Saraiya, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: Department Of Surgery 1650, Selwyn Avenue, Apt # 4a, Bronx, NY 10457 Phone: 718-960-1210 | |
Dr. Jeannine K Giacovelli, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 158r Hawkins St., Bronx, NY 10464 Phone: 917-968-0088 | |
Dr. Eugene Michael Edynak, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 2015 Grand Concourse, Bronx, NY 10453 Phone: 718-299-7295 Fax: 718-299-6797 | |
Howard R Doyle, MD Surgery Medicare: May Accept Medicare Assignments Practice Location: Mmc - Critical Care Medicine Moses Div, 111 East 210th Street, Bronx, NY 10467 Phone: 718-920-2479 |